. 2022 Dec 15;539:144–150. doi: 10.1016/j.cca.2022.12.009

Table 2.

The results of first and second phases of clinical sample validation.

Phase of clinical sample validation	Period of sample collection	TrueNat positive samples			TrueNat negative samples
Phase of clinical sample validation	Period of sample collection	Total positive samples	True positive by RT-PSR	True positive sample for RT-PSR (%)	Total negative samples	True negative by RT-PSR	True negative for RT-PSR (%)
First phase	July-August 2021	36	28*	77 %	–	–	–
First phase	September-October 2021	24	23^‘ns’	95.8 %	30	29‘^ns’	96 %
Second phase	January 2022	80	75*	93.7 %	20	20‘^ns’	100 %

*Significant difference in RT-PSR results in comparison to TrueNat test.

^‘ns’No significant difference in RT-PSR results in comparison to TrueNat test.